"It has been a decade since I became symptom-free. Much has transpired since my diagnosis, and perhaps the most rewarding aspect is that I have welcomed three grandchildren into my life. Now, I can actively participate in the lives of five children as a doting grandmother," Katalin reflected.
Her transformative experiences led to the creation of a remarkable book authored by Csilla Mihalicz, titled "For Whom The Sun Came Up Twice". Through personal anecdotes, the book underscores the importance of never giving up the fight and highlights that seemingly hopeless cases can often be cured with effective assistance, wherever one may be in the world. Science's continuous evolution is exemplified by Oncompass Medicine's use of artificial intelligence in therapy planning since 2015.
Throughout its twenty-year journey, Oncompass Medicine's mission has remained unchanged: to provide cutting-edge therapies to as many patients as possible, years ahead of public availability. For instance, the drug that proved effective in Spain in 2013 for Katalin's case was only registered and accessible to cancer patients in Hungary for specific indications in 2019.
Dr. István Peták, the scientific director of Oncompass Medicine, added, "We understand that the path to recovery is arduous and painful for every cancer patient. The past twenty years have been an enduring struggle for Oncompass as well. However, every moment of perseverance has been worthwhile as we achieve success in more and more cancer cases. Over the past two decades, tens of thousands of patients from nearly every corner of the globe have placed their trust in Oncompass Medicine. We are confident that this number will continue to rise in the next twenty years. With a united global effort, we aim to dethrone cancer from its current reign."
To fulfill this ambition, Oncompass Medicine, as a digital healthcare company, intends to expand its support for cancer patients in the future through new self-developed platforms. From molecular diagnostics to follow-up care, OCM aims to establish a global digital safety net for prevention-focused patients and those battling cancer. This net will offer the highest-quality professional support and oversight, accessible to all, even without in-person presence, providing access to the most advanced diagnostic and therapy planning tools based on the latest scientific advancements.